The role of CREB-H transcription factor in triglyceride metabolism

Current Opinion in Lipidology

Volumn 23, Issue 2, 2012, Pages 141-146

  Lee, Ann Hwee ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

apolipoprotein; CREB H; CREB3L3; transcription factor; triglyceride

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 6; ACTIVATING TRANSCRIPTION FACTOR 6ALPHA; ACTIVATING TRANSCRIPTION FACTOR 6BETA; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN 3L1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN 3L2; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN 3L3; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN 3L4; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN H; GLUCOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSCRIPTION FACTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

DNA POLYMORPHISM; DNA SEQUENCE; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL METABOLISM; UNFOLDED PROTEIN RESPONSE;

ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MICE; MICE, KNOCKOUT; MUTATION; TRIGLYCERIDES;

MUS; RODENTIA;

EID: 84858795217     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e3283508fed     Document Type: Review

References (48)

1. Ginsberg HN, Zhang YL, Hernandez-Ono A. Metabolic syndrome: focus on dyslipidemia. Obesity (Silver Spring) 2006; 14 (Suppl 1):41S-49S.
2. Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev 2006; 86:465-514.
3. Abel T, Bhatt R, Maniatis T. A Drosophila CREB/ATF transcriptional activator binds to both fat body-and liver-specific regulatory elements. Genes Dev 1992; 6:466-480.
4. Smolik SM, Rose RE, Goodman RH. A cyclic AMP-responsive elementbinding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family. Mol Cell Biol 1992; 12:4123-4131.
5. Omori Y, Imai J, Watanabe M, et al. CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. Nucleic Acids Res 2001; 29: 2154-2162. (Pubitemid 32472086)
6. Luebke-Wheeler J, Zhang K, Battle M, et al. Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H. Hepatology 2008; 48:1242-1250.
7. Lee JH, Giannikopoulos P, Duncan SA, et al. The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism. Nat Med 2011; 17:812-815.
8. Bailey D, Barreca C, O'Hare P. Trafficking of the bZIP transmembrane transcription factor CREB-H into alternate pathways of ERAD and stressregulated intramembrane proteolysis. Traffic 2007; 8:1796-1814. (Pubitemid 350066690)
9. Zhang K, Shen X,WuJ, et al. Endoplasmic reticulum stress activates cleavage of CREBH to induce a systemic inflammatory response. Cell 2006; 124: 587-599. (Pubitemid 43199443)
10. Brown MS, Ye J, Rawson RB, Goldstein JL. Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 2000; 100:391-398.
11. Ye J, Rawson RB, Komuro R, et al. ER stress induces cleavage of membranebound ATF6 by the same proteases that process SREBPs. Molec Cell 2000; 6:1355-1364. (Pubitemid 32045928)
12. Vecchi C, Montosi G, Zhang K, et al. ER stress controls iron metabolism through induction of hepcidin. Science 2009; 325:877-880.
13. Lee MW, Chanda D, Yang J, et al. Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. Cell Metab 2010; 11:331-339.
14. Brown MS, Goldstein JL. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997; 89:331-340. (Pubitemid 27220877)
15. Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest 2002; 109:1125-1131. (Pubitemid 34496588)
16. Todd DJ, Lee AH, Glimcher LH. The endoplasmic reticulum stress response in immunity and autoimmunity. Nat Rev Immunol 2008; 8:663-674.
17. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nature Rev 2007; 8:519-529. (Pubitemid 46985379)
18. Yamamoto K, Sato T, Matsui T, et al. Transcriptional induction of mammalian ER quality control proteins is mediated by single or combined action of ATF6alpha and XBP1. Dev Cell 2007; 13:365-376. (Pubitemid 47308680)
19. Bailey D, O'Hare P. Transmembrane bZIP transcription factors in ER stress signaling and the unfolded protein response. Antioxid Redox Signal 2007; 9:2305-2321. (Pubitemid 350059018)
20. Asada R, Kanemoto S, Kondo S, et al. The signalling from endoplasmic reticulum-resident bZIP transcription factors involved in diverse cellular physiology. J Biochem 2011; 149:507-518.
21. Kondo S, Murakami T, Tatsumi K, et al. OASIS, a CREB/ATF-family member, modulates UPR signalling in astrocytes. Nat Cell Biol 2005; 7:186-194. (Pubitemid 40268134)
22. Liang G, Audas TE, Li Y, et al. Luman/CREB3 induces transcription of the endoplasmic reticulum (ER) stress response protein Herp through an ER stress response element. Mol Cell Biol 2006; 26:7999-8010. (Pubitemid 44630999)
23. Stirling J, O'Hare P. CREB4, a transmembrane bZip transcription factor and potential new substrate for regulation and cleavage by S1P. Mol Biol Cell 2006; 17:413-426. (Pubitemid 43049493)
24. Brown MS, Goldstein JL. Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL. J Lipid Res 2009; 50 (Suppl):S15-27.
25. Shen J, Chen X, Hendershot L, Prywes R. ER stress regulation of ATF6 localization by dissociation of BiP/GRP78 binding and unmasking of Golgi localization signals. Dev Cell 2002; 3:99-111. (Pubitemid 34778399)
26. Hwang-Verslues WW, Sladek FM. HNF4alpha: role in drug metabolism and potential drug target? Curr Opin Pharmacol 2010; 10:698-705.
27. Danno H, Ishii KA, Nakagawa Y, et al. The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. Biochem Biophys Res Commun 2010; 391:1222-1227.
28. Vegiopoulos A, Herzig S. Glucocorticoids, metabolism and metabolic diseases. Mol Cell Endocrinol 2007; 275:43-61. (Pubitemid 47259280)
29. Duval C, Muller M, Kersten S. PPARalpha and dyslipidemia. Biochim Biophys Acta 2007; 1771:961-971.
30. Gentile CL, Wang D, Pfaffenbach KT, et al. Fatty acids regulate CREBh via transcriptional mechanisms that are dependent on proteasome activity and insulin. Mol Cell Biochem 2010; 344:99-107.
31. Chanda D, Kim DK, Li T, et al. Cannabinoid receptor type 1 (CB1R) signaling regulates hepatic gluconeogenesis via induction of endoplasmic reticulum-bound transcription factor cAMP-responsive element-binding protein H (CREBH) in primary hepatocytes. J Biol Chem 2011; 286:27971-27979.
32. Tam J, Liu J, Mukhopadhyay B, et al. Endocannabinoids in liver disease. Hepatology 2011; 53:346-355.
33. Chan CP, Mak TY, Chin KT, et al. N-linked glycosylation is required for optimal proteolytic activation of membrane-bound transcription factor CREB-H. J Cell Sci 2010; 123:1438-1448.
34. Zhang C, Wang G, Zheng Z, et al. ER-tethered transcription factor crebh regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress. Hepatology 2011. [Epub ahead of print]
35. Jong MC, Hofker MH, Havekes LM. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. Arterioscler Thromb Vasc Biol 1999; 19:472-484. (Pubitemid 29135144)
36. Merkel M, Loeffler B, Kluger M, et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycanbound lipoprotein lipase. J Biol Chem 2005; 280:21553-21560. (Pubitemid 40805722)
37. Marcais C, Verges B, Charriere S, et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 2005; 115:2862-2869. (Pubitemid 41434413)
38. Merkel M, Eckel RH, Goldberg IJ. Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res 2002; 43:1997-2006. (Pubitemid 35471065)
39. Pennacchio LA, Olivier M, Hubacek JA, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001; 294:169-173. (Pubitemid 32952971)
40. Kliewer SA, Mangelsdorf DJ. Fibroblast growth factor 21: from pharmacology to physiology. Am J Clin Nutr 2010; 91:254S-257S.
41. Gong J, Sun Z, Li P. CIDE proteins and metabolic disorders. Curr Opin Lipidol 2009; 20:121-126.
42. Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol 2011; 22:247-253.
43. Hegele RA. Plasma lipoproteins: genetic influences and clinical implications. Nat Rev Genet 2009; 10:109-121.
44. Asimit J, Zeggini E. Testing for rare variant associations in complex diseases. Genome Med 2011; 3:24.
45. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008; 40:695-701. (Pubitemid 351748875)
46. Johansen CT, Wang J, McIntyre AD, et al. Excess of rare variants in non-GWAS candidate genes in patients with hypertriglyceridemia. Circ Cardiovasc Genet 2011. [Epub ahead of print]
47. Hanson RW, Reshef L. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Annu Rev Biochem 1997; 66:581-611. (Pubitemid 27274668)
48. Chin KT, Zhou HJ, Wong CM, et al. The liver-enriched transcription factor CREB-H is a growth suppressor protein underexpressed in hepatocellular carcinoma. Nucleic Acids Res 2005; 33:1859-1873.